| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.23093 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcb.23093 |
| https://doi.org/10.1002/jcb.23093 | ||
| https://europepmc.org/articles/PMC3111873 | ||
| https://europepmc.org/articles/pmc3111873?pdf=render | ||
| https://europepmc.org/articles/PMC3111873?pdf=render | ||
| https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.23093 | ||
| P932 | PMC publication ID | 3111873 |
| P698 | PubMed publication ID | 21381078 |
| P5875 | ResearchGate publication ID | 50291624 |
| P2093 | author name string | Nima Alamdari | |
| Per-Olof Hasselgren | |||
| Zaira Aversa | |||
| Patricia Gonnella | |||
| Victoria Petkova | |||
| Steven Tizio | |||
| P2860 | cites work | Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes | Q24534193 |
| CCAAT/enhancer-binding proteins: structure, function and regulation | Q24534323 | ||
| TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes | Q24538709 | ||
| Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy | Q24555065 | ||
| Interaction and functional collaboration of p300 and C/EBPβ | Q24644296 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| The UCSC Genome Browser Database | Q27861125 | ||
| Protein degradation by the ubiquitin-proteasome pathway in normal and disease states | Q28243121 | ||
| Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting | Q28363312 | ||
| C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle | Q28565301 | ||
| Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent | Q28570470 | ||
| Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle | Q28574576 | ||
| Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy | Q28582211 | ||
| FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells | Q29614482 | ||
| FoxO3 controls autophagy in skeletal muscle in vivo | Q29614483 | ||
| Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy | Q29619282 | ||
| Glucocorticoids and muscle catabolism | Q33716942 | ||
| Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes | Q33980095 | ||
| Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation | Q34115660 | ||
| Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle | Q34215201 | ||
| DNA Binding of the Glucocorticoid Receptor Is Not Essential for Survival | Q34469789 | ||
| PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription | Q34575428 | ||
| Regulation of muscle protein synthesis during sepsis and inflammation | Q34628735 | ||
| MuRF1-dependent regulation of systemic carbohydrate metabolism as revealed from transgenic mouse studies | Q34777671 | ||
| TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle | Q34997547 | ||
| Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle | Q35824460 | ||
| Novel aspects on the regulation of muscle wasting in sepsis | Q36241903 | ||
| Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP | Q36447976 | ||
| The IkappaB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy | Q37072407 | ||
| The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. | Q37120241 | ||
| The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. | Q37320841 | ||
| Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia | Q37345273 | ||
| Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids | Q37350232 | ||
| Crossroads of cytokine signaling--the chase to stop muscle cachexia | Q37406634 | ||
| The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts | Q38297445 | ||
| Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. | Q38306475 | ||
| Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPbeta in cultured myotubes | Q38331467 | ||
| Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity | Q39714611 | ||
| Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism | Q39751365 | ||
| Efficient transfection of mouse-derived C2C12 myoblasts using a matrigel basement membrane matrix | Q39861889 | ||
| The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle | Q40190344 | ||
| Treatment of cultured myotubes with the proteasome inhibitor beta-lactone increases the expression of the transcription factor C/EBPbeta | Q40229403 | ||
| IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 | ||
| The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors | Q40559475 | ||
| Dual regulation of phosphorylation and dephosphorylation of C/EBPbeta modulate its transcriptional activation and DNA binding in response to growth hormone | Q40706183 | ||
| Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3. | Q40816906 | ||
| Effects of dexamethasone on protein degradation and protease gene expression in rat L8 myotube cultures | Q41367839 | ||
| Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes | Q41925362 | ||
| CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription | Q42833598 | ||
| Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control | Q44991663 | ||
| The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. | Q45855217 | ||
| Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. | Q47370718 | ||
| The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions | Q57272895 | ||
| Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle | Q73208228 | ||
| The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis | Q73598526 | ||
| C/EBPbeta regulates TNF induced MnSOD expression and protection against apoptosis | Q79931460 | ||
| Expression and activity of C/EBPbeta and delta are upregulated by dexamethasone in skeletal muscle | Q81315131 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dexamethasone | Q422252 |
| P304 | page(s) | 1737-1748 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1 | |
| C/EBPβ regulates dexamethasone‐induced muscle cell atrophy and expression of atrogin‐1 and MuRF1 | |||
| P478 | volume | 112 |
| Q36198934 | Acetylation and deacetylation—novel factors in muscle wasting |
| Q35422257 | C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting |
| Q39226505 | CaMKII activity is reduced in skeletal muscle during sepsis |
| Q46415736 | Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model |
| Q49887275 | Epigenetics of cancer-associated muscle catabolism |
| Q30408570 | Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity |
| Q38577674 | F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities |
| Q38092488 | Metabolic functions of glucocorticoid receptor in skeletal muscle |
| Q43594462 | Molecules modulating gene transcription during muscle wasting in cancer, sepsis, and other critical illness |
| Q28577088 | Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells |
| Q34652034 | PPARβ/δ Regulates Glucocorticoid- and Sepsis-Induced FOXO1 Activation and Muscle Wasting |
| Q60907851 | Protein Prevents Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes |
| Q39429075 | Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism |
| Q47983891 | Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes |
| Q39330164 | β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy |
Search more.